Drugs News and Research

RSS

Leading medical journal says homeopathy no better than dummy drugs

Leading medical journal The Lancet has rubbished homeopathy and says it is no more value than dummy drugs.

29 Aug 2005

Supermolecules strike blow to cancer cells

Chemistry and biology researchers at Virginia Tech have enhanced the abilities of the molecules they are creating to deliver killing blows to cancer cells. The man-made molecular complexes enter cancer cells and, when signaled, deliver killing medicine or cause the cell to change.

29 Aug 2005

Minimally invasive prostate removal aided by a robot has possible benefits, high cost

Although minimally invasive prostate removal aided by a robot can lead to less blood loss, shorter hospital stays and fewer complications, there is no evidence that the procedure improves cure rates, according to a new technology assessment.

29 Aug 2005

Study reveals functional link between emotion processing centers in the brain and certain physiological processes relevant to disease

The mere mention of a stressful word like "wheeze" can activate two brain regions in asthmatics during an attack, and this brain activity may be associated with more severe asthma symptoms, according to a study by University of Wisconsin-Madison researchers and collaborators.

29 Aug 2005

New vaccine protects more effectively against tuberculosis

Max Planck researchers have uncovered the mechanism by which the new genetically engineered tuberculosis vaccine functions.

28 Aug 2005

Neurotransmitter orexin influences reward processing - associated with pleasure and reward pathways in the brain

Researchers at the University of Pennsylvania School of Medicine have discovered that the recently identified neurotransmitter orexin (also known as hypocretin) influences reward processing by activating neurons in the lateral hypothalamus region of the brain.

28 Aug 2005

Compound might defeat African sleeping

One of the most devastating diseases in sub-Saharan Africa almost disappeared in the late 1950s.

26 Aug 2005

Ichor Medical Systems issued key patent

Ichor Medical Systems today announced that it has been issued a patent that protects vital elements of the company's technology.

25 Aug 2005

Protein snapin has potential as a drug target in therapies aimed at learning and memory disorders

Rutgers' Bonnie Firestein likens nerve cells to trees -- some are short and bushy with many branches while others are tall with a few branches coming out of one or two main trunks. Different branching patterns correlate with specific disorders and Firestein's quest is to discover how these dissimilar patterns come about and why.

25 Aug 2005

Experimental immunusuppressant drug preserves transplanted kidneys

An international team of transplant physicians has shown that the investigational drug belatacept (LEA29Y) preserves transplanted kidney function as effectively as cyclosporine, the drug most commonly used to prevent the immune system from rejecting transplanted organs.

24 Aug 2005

Drug company donates bird flu vaccine to World Health Organization

A donation by Swiss drug maker Roche, of enough of its Tamiflu antiviral drug to treat 3 million people against birdflu, could slow the spread of the outbreak among humans, especially in countries too poor to afford their own stockpile.

24 Aug 2005

Prince Charles champions alternative healthcare

According to media in the UK, Prince Charles has commissioned a report into how the government could save money by using alternative medicine in the public healthcare system.

24 Aug 2005

New drug that selectively blocks immune responses protects kidneys after transplant

In an international clinical trial, a new drug that selectively blocks immune responses has proved as effective in preventing acute kidney transplant rejection as cyclosporine, the standard anti-rejection treatment.

24 Aug 2005

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Lorus Therapeutics has announced the continued success in the development of its small molecule anticancer program with the selection of a sub-class of lead molecules from the Company's small molecule program.

24 Aug 2005

Taking aspirin longterm could reduce colorectal cancer risk

According to new report from the Nurses' Health Study (NHS), regular, long-term aspirin use can significantly reduce the risk of colorectal cancer.

24 Aug 2005

First human gene mutation that causes extreme farsightedness

Working with an Amish-Mennonite family tree, Johns Hopkins researchers at the Wilmer Eye Institute have discovered what appears to be the first human gene mutation that causes extreme farsightedness.

24 Aug 2005

First direct evidence that endorphins play a role in the phenomenon known as the placebo effect

Just thinking that a medicine will relieve pain is enough to prompt the brain to release its own natural painkillers, and soothe painful sensations, a new University of Michigan study finds.

23 Aug 2005

European Rare Diseases Therapeutic Initiative could provide an important new mechanism for developing new drugs

Because of the very high costs in developing drugs for rare genetic diseases, and the low return on investment, the pharmaceutical industry has rarely developed specific treatments for many of these diseases.

23 Aug 2005

Aspirin use can significantly reduce the risk of colorectal cancer

A new report from the Nurse's Health Study finds that regular, long-term aspirin use can significantly reduce the risk of colorectal cancer, as suggested by several earlier studies.

23 Aug 2005

Benefits of MAO-B inhibitors are small but may be worthwhile in some patients with early Parkinson's disease

A class of drugs known as MAO-B inhibitors may be effective in improving motor symptoms in people with early Parkinson's disease and may delay the need for treatment with other drugs, according to a new systematic review of current evidence.

23 Aug 2005

Drugs News and Research

Leading medical journal says homeopathy no better than dummy drugs

Supermolecules strike blow to cancer cells

Minimally invasive prostate removal aided by a robot has possible benefits, high cost

Study reveals functional link between emotion processing centers in the brain and certain physiological processes relevant to disease

New vaccine protects more effectively against tuberculosis

Neurotransmitter orexin influences reward processing - associated with pleasure and reward pathways in the brain

Compound might defeat African sleeping

Ichor Medical Systems issued key patent

Protein snapin has potential as a drug target in therapies aimed at learning and memory disorders

Experimental immunusuppressant drug preserves transplanted kidneys

Drug company donates bird flu vaccine to World Health Organization

Prince Charles champions alternative healthcare

New drug that selectively blocks immune responses protects kidneys after transplant

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Taking aspirin longterm could reduce colorectal cancer risk

First human gene mutation that causes extreme farsightedness

First direct evidence that endorphins play a role in the phenomenon known as the placebo effect

European Rare Diseases Therapeutic Initiative could provide an important new mechanism for developing new drugs

Aspirin use can significantly reduce the risk of colorectal cancer

Benefits of MAO-B inhibitors are small but may be worthwhile in some patients with early Parkinson's disease

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News